Fatal disseminated fusariosis presenting initially as tonsillitis

References

1. Al‐Abdely H.M. ( 2004). Management of rare fungal infections. Curr Opin Infect Dis 17:527–532 [CrossRef]
   [Google Scholar]
2. Boutati E.I., Anaissie E.J. ( 1997). Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood 90:999–1008
   [Google Scholar]
3. Campo M., Lewis R.E., Kontoyiannis D.P. ( 2010). Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009. J Infect 60:331–337 [CrossRef]
   [Google Scholar]
4. Diekema D.J., Messer S.A., Hollis R.J., Jones R.N., Pfaller M.A. ( 2003). Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 41:3623–3626 [CrossRef]
   [Google Scholar]
5. Hospenthal D. ( 2009). Fusarium species. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 7th. edn, pp. 3369–3370 Edited by Mandell G., Benent J., Dolin R. Philadelphia: PA: Elsevier;
   [Google Scholar]
6. Lortholary O., Obenga G., Biswas P., Caillot D., Chachaty E., Bienvenu A.L., Cornet M., Greene J., Herbrecht R. other authors ( 2010). International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54:4446–4450 [CrossRef]
   [Google Scholar]
7. Nucci M., Anaissie E. ( 2002). Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 35:909–920 [CrossRef]
   [Google Scholar]
8. Nucci M., Anaissie E.J., Queiroz‐Telles F., Martins C.A., Trabasso P., Solza C., Mangini C., Simões B.P., Colombo A.L. other authors( 2003). Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98:315–319 [CrossRef]
   [Google Scholar]
9. Paphitou N.I., Ostrosky‐Zeichner L., Paetznick V.L., Rodriguez J.R., Chen E., Rex J.H. ( 2002). In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother 46:3298–3300 [CrossRef]
   [Google Scholar]
10. Perfect J.R. ( 2005). Treatment of non‐Aspergillus moulds in immunocompromised patients with amphotericin B lipid complex. Clin Infect Dis 40:S401–S408 [CrossRef]
    [Google Scholar]
11. Raad I.I., Hachem R.Y., Herbrecht R., Graybill J.R., Hare R., Corcoran G., Kontoyiannis D.P. ( 2006). Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 42:1398–1403 [CrossRef]
    [Google Scholar]